NRDC v. E. Scott Pruitt et al

Reference :

1:17-CV-02034-TSC

Complaint date :

October 3, 2017

Status :

Final judgment

Place of jurisdiction :

United States, Washignton DC

Plaintiffs types :

Environmental NGOs

Plaintiffs names :

Natural Resources Defense Council

Defendants :

EPA, Andrew Wheeler, Scott Pruitt, Michael S. Regan

Lawyers for Health and Environmental Justice :

Aaron Colangelo, Rebecca J. Riley, Daniel L. Raichel, Jolie D. McLaughlin, Lucas J. Rhoads

Case nature :

Administrative

Specificities :

Stipulated Settlement Agreement, Civil action for injunctive and declaratory relief

Type(s), Product(s), Active substance(s) :

Imidacloprid, Dinotefuran, Acetamiprid, Neonicotinoid,

Requests :

NRDC ask for EPA to take into account the effects of dangerous active ingredients on 95 products regarding the Endangered Species Act

Name of the Court :

United States District Court for the District of Columbia of Washignton DC, United States

Jurisdiction level :

Decision date :

January 15, 2021

Decision nature :

Partially Positive

Decision content :

Agreement that requires EPA to begin evaluating the impacts of imidacloprid on endangered and threatened bees, butterflies, birds and other wildlife as required by ESA on1/15/2021; .EPA required to evaluate the effects of acetamiprid and dinotefuran on endangered and threatened species by October 2024 on 3/7/2022.

Legal basis :

Court Ruling :

Link to the ruling

Summary :

Plaintiff files an action against EPA, alleging that it violated the Endangered Species Act (ESA), by failing to consult on the effects of 95 pesticide products registrations containing neonicotinoids: acetamiprid, dinotefuran, or imidacloprid, on Oct. 3, 2017. On Feb. 8, 2018, Parties entered into a Stipulation of Partial Dismissal of any and all claims related to 36 pesticide products. On January 15, 2021, Parties agreed to a partial settlement agreement which requires EPA to initiate consultation on the effects of imidacloprid by June 30, 2022. and to meet to resolve the remaining issue on acetamiprid and dinotefuran. On March 7, 2022, EPA and NRDC settled NRDC’s remaining claims related to acetamiprid and dinotefuran. EPA is required to evaluate the effects of these neonics on endangered and threatened species by October 2024. If EPA determines that these insecticides are likely to harm endangered or threatened species, the settlement requires the EPA to begin the formal consultation process required under the Endangered Species Act (ESA). That process should result in significant restrictions on use of these products to protect threatened and endangered species and their habitats.

Scientific references :

No scientifice reference for this case.